#Biomanufacturing / Pharmaceutical Services #Industrial Biotech
- In vivo
- Toxicity
- Environment
- Endocrine
As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.
Discover >Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.
Discover >Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.
Discover >Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.
Discover >#Biomanufacturing / Pharmaceutical Services #Industrial Biotech
WatchFrog markets in vivo biotechnological solutions for environmental risk assessment and the evaluation of the therapeutic, toxic or pollutant potential of all types of chemical, cosmetic or pharmaceutical compounds.
BACKGROUND
WatchFrog is a service and contract testing provider for major industrial customers, all of whom are world leaders in their respective fields: water, energy, consumer goods, fine chemicals and pharmaceuticals.
WatchFrog has a routine screening platform that meets the quality standards required by its industrial customers.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
CUSTOMER REFERENCES / COLLABORATIONS / HIGHLIGHTS
COLLABORATIONS SOUGHT
In view of the flexibility of WatchFrog’s technology, we are looking for industrial partners to take up new challenges in lead optimization or environmental risk evaluation.
Annual turnover: €900K
2 patents
14 staff members
Strengths:
Miniature, industrializable vertebrate models.
A technology platform that complies with international quality standards for the production of aquatic material and molecular screening.
Innovation assets:
Real-time monitoring of environmental risks on industrial sites.
Other facts:
the creation of custom disease models.
In same field